RWE

1. Data Collection and Management

• Patient Registries: Collecting and managing disease-specific patient data for outcome tracking and long-term therapy monitoring.
• Electronic Health Records (EHR/EMR): Analyzing routine clinical care data including diagnoses, treatments, prescriptions, follow-up care.
• Claims Data: Studying healthcare utilization, treatment patterns & therapy-related costs.
• Patient-Reported Outcomes (PROs): Direct patient input on health status, quality of life, treatment satisfaction.
• Mobile Health Data: Using wearable devices, apps & sensor-based data for real-time behavior and health tracking.

2. Observational Studies

• Cohort Studies: Tracking patients over time for long-term outcomes (prospective or retrospective).
• Case-Control Studies: Comparing affected patients with control groups to identify causes or treatment effects.
• Cross-Sectional Studies: Single-time-point evaluation for prevalence and treatment analysis.

3. Effectiveness and Safety Analysis

• Comparative Effectiveness Research (CER): Comparing real-world performance of multiple interventions.
• Safety Monitoring: Adverse event tracking and safety evaluation beyond clinical trials.
• Long-Term Outcomes: Measuring durability and impact of therapies in chronic conditions.

4. Real-World Data Analysis

• Statistical & Machine Learning Techniques: Predictive modeling, survival analysis, propensity matching.
• Big Data Analytics: Large-scale data processing from EHR, claims, and device sources.
• Risk Adjustment: Correcting variance in patient conditions for fair comparisons.

5. Outcomes Research

• Quality of Life (QoL) Studies
• Health-Related QoL (HRQoL) using EQ-5D, SF-36, etc.
• Economic Outcomes: Cost-effectiveness, cost-benefit & resource utilization.

6. Market Access & Reimbursement Support

• Value Dossier Preparation for payers.
• Reimbursement Strategy for market entry.
• Payer & Policy Engagement to support formulary decisions.

7. Regulatory Support

• Post-Marketing Surveillance: Monitoring real-world product safety & performance.
• Regulatory Submissions: RWE support for new indications, label expansion & approvals.
• Risk Management Plans (RMPs) using real-world safety insights.

8. Patient-Centric Research

• Patient Preferences: Understanding real treatment needs & expectations.
• Patient Engagement: Real-world experience included in research and decisions.

Applications of RWE Services

• Drug Development • HTA Support • Market Access • Regulatory Decision Making
• Comparative Effectiveness Research (CER) • Patient Care & Outcomes

Benefits of RWE Services

• Broader Generalizability • Cost-Effectiveness • Faster Insights
• Regulatory Flexibility • Patient-Centered Outcomes

Key Stakeholders in RWE Services

• Pharmaceutical & Biotech Companies
• Medical Device Manufacturers
• Healthcare Providers • Payers & Insurers
• Regulatory Authorities (FDA, EMA) • Academia & Researchers